Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ezgi Erbasan
Institution:
Akdeniz University
Observed institution:
Akdeniz University
ORCID:
0009-0003-3299-5911
Observed ORCID:
0009-0003-3299-5911
OpenAlex ID:
A5119822673
Prime Editing: The Next Frontier in Precision Gene Therapy
2025
·
Melike Aliciaslan
, Ezgi Erbasan
, et al.
·
The Journal of Gene Medicine
·
12
Advances in CRISPR Base Editing: From Molecular Evolution to Therapeutic Applications in Genomic Medicine
2026
·
Melike Aliciaslan
, Ezgi Erbasan
, et al.
·
Journal of Cellular and Molecular Medicine
·
6
Therapeutic precision gene editing of cholesterol pathways as a gene therapy strategy for cardiovascular disease
2025
·
Ezgi Erbasan
, Melike Aliciaslan
, et al.
·
Gene Therapy
·
4
Lantidra (donislecel) in type 1 diabetes: An in‐depth analysis of pharmacology, clinical effectiveness, safety, and the therapeutic role of the first FDA ‐approved allogeneic islet cell therapy
2025
·
Ezgi Erbasan
, Melike Aliciaslan
, et al.
·
Diabetic Medicine
·
2
Lentiviral GLP-1 gene therapy elicits developmental stage–dependent β-cell regeneration in diabetic rats
2026
·
Ezgi Erbasan
, Melike Aliciaslan
, et al.
·
Journal of Molecular Medicine
·
1
PDF
A Comprehensive Evaluation of CAR-T Cell Gene Therapy, Tracing its Revolutionary Clinical Breakthroughs and Advancements Towards Next-Generation Engineering
2026
·
Melike Aliciaslan
, Ezgi Erbasan
, et al.
·
Expert Reviews in Molecular Medicine
·
1
PDF
Spinal muscular atrophy as a blueprint for precision therapy in neuromuscular disease
2026
·
Busra Cetin
, Melike Aliciaslan
, et al.
·
Expert Reviews in Molecular Medicine
PDF
Show more works
View as search
Works count:
7
Citation count:
26
H-index:
3
I10-index:
1
Year
Topic
Type
